Stockreport

IMV collaborates with Merck to evaluate DPX-Survivac in combination with KEYTRUDA across five solid tumor indications [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF IMV collaborates with Merck to evaluate DPX-Survivac in combination with KEYTRUDA across five solid tumor indications [Read more]